OHSU in the news

Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection)

Globe Newswire September 21, 2022
Fennec Pharmaceuticals announces the FDA approval of PEDMARK to reduce the risk of ototoxicity associated with cisplatin in pediatric patients age 1 month and older with localized, non-metastatic solid tumors. The company's CEO says: "We would like to thank the patients, their families, physicians, investigators, employees, consultants and the entire research team at Oregon Health & Science University, who have contributed to the development of PEDMARK"

Cancer death rates continue to fall, driven by new treatments and improved screening

NBC News Think September 21, 2022
The American Association for Cancer Research publishes its latest cancer progress report highlighting how basic, translational and clinical cancer research remain vitally important to improving health and saving lives. AACR President Lisa Coussens, Ph.D., says: "You can’t stop funding basic science now with the belief that the current treatments will be good enough. Investing in basic science has a huge payoff to the public.”

OHSU Expands Street Nursing Teams In Southern Oregon

The Lund Report September 21, 2022
In a story by The Lund Report, Rachel Richmond, M.S.N., RN, and Heather C. Voss, Ph.D., RN, describe the OHSU School of Nursing’s Ashland-based Street Nursing Team’s efforts to provide health services for Southern Oregonians experiencing homelessness while also preparing future nurses to do the same.
See more stories